SAB Biotherapeutics, Inc. — 4 Filings
110 4 filings on record
This page lists all 4 filings submitted to the SEC by SAB Biotherapeutics, Inc. (SABSW), sorted by most recent first. Each row links to the full filing on EdgarLookup. SAB Biotherapeutics, Inc. has filed 110 4 documents with the SEC since 2020. To view all SEC filings by SAB Biotherapeutics, Inc., see the full filings list.
All
10-K
10-K/A
10-Q
25-NSE
3
4
4/A
424B3
424B4
424B5
425
5
8-A12B
8-K
8-K/A
AW
CERT
CORRESP
D
DEF 14A
DEFA14A
DRSLTR
EFFECT
NT 10-K
NT 10-Q
POS AM
PRE 14A
RW
S-1
S-1/A
S-3
S-3/A
S-4
S-4/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D
SCHEDULE 13D/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 4 | 4 | 0001193125-26-124231 | Mar 25, 2026 | Mar 24, 2026 |
| 4 | 4 | 0001193125-26-039508 | Feb 5, 2026 | Feb 3, 2026 |
| 4 | 4 | 0001193125-26-039537 | Feb 5, 2026 | Feb 3, 2026 |
| 4 | 4 | 0001193125-26-039564 | Feb 5, 2026 | — |
| 4 | 4 | 0001193125-26-039524 | Feb 5, 2026 | Feb 3, 2026 |
| 4 | 4 | 0001193125-26-039577 | Feb 5, 2026 | Feb 3, 2026 |
| 4 | 4 | 0001193125-26-006427 | Jan 7, 2026 | Jan 5, 2026 |
| 4 | 4 | 0001193125-26-006435 | Jan 7, 2026 | Jan 5, 2026 |
| 4 | 4 | 0001193125-25-324970 | Dec 18, 2025 | Dec 16, 2025 |
| 4 | 4 | 0001193125-25-324991 | Dec 18, 2025 | Dec 16, 2025 |
| 4 | 4 | 0001193125-25-324976 | Dec 18, 2025 | Dec 16, 2025 |
| 4 | 4 | 0001193125-25-325002 | Dec 18, 2025 | Dec 16, 2025 |
| 4 | 4 | 0001193125-25-325007 | Dec 18, 2025 | Dec 16, 2025 |
| 4 | 4 | 0001193125-25-324963 | Dec 18, 2025 | Dec 16, 2025 |
| 4 | 4 | 0001193125-25-317688 | Dec 12, 2025 | Dec 11, 2025 |
| 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001012975-25-000592 | Oct 1, 2025 | Sep 29, 2025 |
| 4 | 4 | 0001193125-25-226846 | Oct 1, 2025 | Sep 29, 2025 |
| 4 | 4 | 0001193125-25-211490 | Sep 22, 2025 | Sep 19, 2025 |
| 4 | 4 | 0000950170-25-112043 | Aug 28, 2025 | Aug 26, 2025 |
| 4 | 4 | 0000950170-25-112045 | Aug 28, 2025 | Aug 26, 2025 |
| 4 | 4 | 0000950170-25-112047 | Aug 28, 2025 | Aug 26, 2025 |
| 4 | 4 | 0000950170-25-112056 | Aug 28, 2025 | Aug 26, 2025 |
| 4 | 4 | 0000950170-25-112077 | Aug 28, 2025 | Aug 26, 2025 |
| 4 | 4 | 0000950170-25-098365 | Jul 24, 2025 | Jul 22, 2025 |
| 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-25-013136 | Jul 24, 2025 | Jul 22, 2025 |
| 4 | 4 | 0000950170-25-048551 | Apr 1, 2025 | Mar 27, 2025 |
| 4 | 4 | 0000950170-24-141672 | Dec 31, 2024 | Dec 18, 2024 |
| 4 | 4 | 0000950170-24-121563 | Nov 5, 2024 | Nov 1, 2024 |
| 4 | 4 | 0000950170-24-096405 | Aug 13, 2024 | Aug 12, 2024 |
| 4 | 4 | 0000950170-24-084293 | Jul 17, 2024 | Jul 15, 2024 |
| 4 | 4 | 0000950170-24-084294 | Jul 17, 2024 | Jul 15, 2024 |
| 4 | 4 | 0000950170-24-084296 | Jul 17, 2024 | Jul 15, 2024 |
| 4 | 4 | 0000950170-24-084295 | Jul 17, 2024 | Jul 15, 2024 |
| 4 | 4 | 0000950170-24-084292 | Jul 17, 2024 | Jul 15, 2024 |
| 4 | 4 | 0000950170-24-084290 | Jul 17, 2024 | Jul 15, 2024 |
| 4 | 4 | 0000950170-24-084291 | Jul 17, 2024 | Jul 15, 2024 |
| 4 | 4 | 0000950170-24-084299 | Jul 17, 2024 | Jul 15, 2024 |
| 4 | 4 | 0000950170-24-084288 | Jul 17, 2024 | Jul 15, 2024 |
| 4 | 4 | 0000950170-24-019460 | Feb 23, 2024 | Feb 21, 2024 |
| 4 | 4 | 0000950170-24-019434 | Feb 23, 2024 | Feb 21, 2024 |
| 4 | 4 | 0000950170-24-019441 | Feb 23, 2024 | Feb 21, 2024 |
| 4 | 4 | 0000950170-24-019430 | Feb 23, 2024 | Feb 21, 2024 |
| 4 | 4 | 0000950170-24-019432 | Feb 23, 2024 | Feb 21, 2024 |
| 4 | 4 | 0000950170-23-068922 | Dec 8, 2023 | Dec 7, 2023 |
| 4 | 4 | 0000950170-23-066901 | Nov 30, 2023 | Nov 29, 2023 |
| 4 | 4 | 0000950170-23-067072 | Nov 30, 2023 | — |
| 4 | 4 | 0000950170-23-066394 | Nov 28, 2023 | Nov 24, 2023 |
| 4 | 4 | 0000950170-23-066395 | Nov 28, 2023 | Nov 24, 2023 |
| 4 | STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES | 0001062993-23-021502 | Nov 28, 2023 | Nov 24, 2023 |
| 4 | 4 | 0000950170-23-063918 | Nov 14, 2023 | Nov 10, 2023 |